Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Biological vulnerability to depressive disorders]

M F Poirier-Littré1

  • 1Service Hospitalo-Universitaire de Santé mentale et de Thérapeutique, Hôpital Sainte-Anne, Paris.

L'Encephale
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New statistical proposals to evaluate the benefit/risk ratio of long-term treatment of depression: application to a one-year double-blind study comparing medifoxamine with fluoxetine.

Clinical drug investigation·2008
Same author

Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia.

The British journal of psychiatry : the journal of mental science·1997
Same author

[Prolactinemia and predictability of therapeutic response of schizophrenic patients in acute decompensation].

L'Encephale·1996
Same author

Factorial structure of the 17-item Hamilton Depression Rating Scale.

Acta psychiatrica Scandinavica·1995
Same author

[Social adjustment and depression: value of the SAS-SR (Social Adjustment Scale Self-Report)].

L'Encephale·1995
Same author

[Application of a structured interview guide adapted to 4 depression scales].

L'Encephale·1994
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

Researchers have sought biological markers for depression for 20 years, progressing through neurotransmitter, ligand, and functional approaches. Current research emphasizes system interactions over individual components for depression insights.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Context:

  • Over two decades of research have focused on identifying biological markers for depression.
  • Technological advancements have driven three distinct stages in this research: neurotransmitter analysis, radioligand binding studies, and functional approaches.

Purpose:

  • To review the historical progression and current trends in the search for biological markers of depression.
  • To highlight the shift towards understanding system interactions (neurological, immunological, endocrine) in depression etiology.

Summary:

  • Early research focused on neurotransmitter activity and receptor binding, with limited etiological or diagnostic success.
  • The current paradigm emphasizes functional, systemic approaches, examining interactions between neurological, immunological, and endocrine systems.

Related Experiment Videos

  • Stress-induced biochemical modifications, neuroplasticity, and genetic predispositions are key areas of investigation, with "kindling" models and "depression memory" offering insights.

    • Impact:

    • The shift to systemic interaction analysis offers a more comprehensive understanding of depression's complex biological underpinnings.
    • Identifying specific biological markers could lead to improved diagnostic tools and targeted therapeutic strategies for depression.
    • Understanding the interplay of genetics, environment, and neurobiology is crucial for developing effective interventions for mood disorders.